Status:
RECRUITING
Evaluation of a New Multiplex Quantitative PCR Technique for the Diagnosis of Echinococcosis
Lead Sponsor:
Centre Hospitalier Universitaire de Besancon
Conditions:
Echinococcosis
Diagnosis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Echinococcosis is a severe parasitosis caused by the development of the tapeworm larva Echinococcus multilocularis, responsible for alveolar echinococcosis (AE) or Echinococcus granulosus, responsible...
Eligibility Criteria
Inclusion Criteria:
- Men and women aged >18 years with a diagnosis of echinococcosis (Alveolar Echinococcosis or Cystic Echinococcosis) established according to the reference criteria
- Signature of the informed consent form indicating that the subject has understood the purpose and the procedures required by the study and that he agrees to participate in the study and to comply with the requirements and restrictions about this study
- Affiliation to a French social security scheme or beneficiary of such a scheme.
Exclusion Criteria:
- Legal incapacity or limited legal capacity
- Subject unlikely to cooperate in the study and/or low cooperation anticipated by the investigator
- Subject without health insurance
- Pregnant woman
- Subject being in the period of exclusion from another study or provided by the "national volunteer file".
Key Trial Info
Start Date :
October 24 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2026
Estimated Enrollment :
43 Patients enrolled
Trial Details
Trial ID
NCT05824442
Start Date
October 24 2023
End Date
October 1 2026
Last Update
February 1 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
MILLON
Besançon, France, 25000